期刊文献+

代谢综合征肾损害:已知与未知 被引量:12

原文传递
导出
摘要 代谢综合征(metabolic syndrome,MS)由世界卫生组织(WHO)于1998年正式命名,近年来,MS发病率迅速增长。不但受到内分泌及心血管病学科充分的重视,而且,由于它还能引起或加重慢性肾脏病(CKD),因此越来越受到肾脏病医师的关注。
作者 谌贻璞
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2006年第7期381-382,共2页 Chinese Journal of Nephrology
  • 相关文献

参考文献10

  • 1Alberti KG,Zimmet PZ.Definition,diagnosis and classification of diabetes mellitus and its complications.Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.Diabet Med,1998,15:539-553.
  • 2World Health Organization.Definition,diagnosis and classification of diabetes mellitus and its complications:report of a WHO Consultation.Part 1:diagnosis and classification of diabetes mellitus.WHO/NCD/NCS,1999,31-32.
  • 3Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ).JAMA,2001,285:2486-2497.
  • 4International Diabetes Federation.The IDF consensus worldwide definition of the metabolic syndrome.April 14 2005.http://www.idf.org/webdata/docs/metac_syndrome_def.pdf
  • 5中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3041
  • 6董葆,陈文,程虹,李安,谌贻璞,邹万忠.肥胖相关性局灶节段性肾小球硬化症临床与病理表现[J].中华肾脏病杂志,2002,18(6):389-392. 被引量:32
  • 7Tuttle KR.Renal manifestation of the metabolic syndrome.Nephrol Dial Transplant,2005,20:861-864.
  • 8Cusumano AM,Bodkin NL,Hansen BC,et al.Glomerular hypertrophy is associated with hyperinsulinemia and precedes overt diabetes in aging rhesus monkeys.Am J Kidney Dis,2002,40:1075-1085.
  • 9Kincaid-Smith P.Hypothesis:obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labeled "hypertensive nephrosclerosis".J Hypertens,2004,22:1051-1055.
  • 10Eckel RH,Grundy SM,Zimmet PZ.The metabolic Syndrome.Lancet,2005,365 (9468):1415-1428.

二级参考文献17

  • 1Weisinger JR, Kempson RL, Eldridge FL, et al. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med,1974,81: 440-447.
  • 2Praga M, Hernandez E, Morales E, et al. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant, 2001, 16:1790-1798.
  • 3Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: An emerging epidemic. Kidney Int, 2001, 59:1498 - 1509.
  • 4Adelman R. Obesity and renal disease. Curr Opin Nephrol Hyperten, 2002, 11: 331-335.
  • 5Praga M, Borstein B, Andres A, et al. Nephrotic proteinuria without hypoalbmninemia: clinical characteristics and response to angiotensin-converting enzyme inhibition. Am J Kidney Dis,1991, 17: 330.
  • 6Praga M, Morales E, Herrero JC, et al. Absence of hypoalbuminemaia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltrafion. Am J Kidney Dis, 1999, 33: 52-58.
  • 7Chagnac A, Weinstein T, Korzets A, et al. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol, 2000,F817-F822.
  • 8Anderson PW, Zhang XY, Tiaa J, et al. Insulin and angiotensin Ⅱ are additive in stimulating TGF-beta 1 and matrix mRNAs in mesangial cells. Kidney Int, 1996, 50: 745-753.
  • 9Fujiwara K, Hayashi K, Ozawa Y, et al. Renal protective effect of troglitazone in Wistar fatty rats. Metabolism, 2000, 49:1361-1364.
  • 10Wolf G, Hamann A, Han DC, et al. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells. Kidney Int, 1999,56: 860-872.

共引文献3069

同被引文献132

引证文献12

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部